Dr. Wenfeng Gong is the Deputy Director of Health Innovation and Partnerships at the China Country Office of the Gates Foundation. In this role, he leads a portfolio of health product development collaborations in China and other geographies, working to accelerate the translation, development, and commercialization of medical products—including drugs, vaccines, monoclonal antibodies, diagnostics, medical devices, and vector control technologies—to improve health outcomes in low- and middle-income countries (LMICs). His team plays a critical role in advancing the foundation’s global strategies for the prevention, control, and elimination of priority infectious diseases, including vaccine-preventable diseases, malaria, tuberculosis, HIV, polio, and pneumonia. His work also supports maternal, neonatal, and child nutrition and health innovations, ensuring that life-saving interventions reach those in need.

In addition to his role at the foundation, Wenfeng serves as the Director of the Project Design and Evaluation Committee at the Shanghai Institute for Global Health Innovation, a Review Expert for the National Natural Science Foundation of China-Gates Foundation Collaborative Program on Global Health, an Adjunct Associate Professor at the Duke Global Health Institute, where he also serves on the Board of Advisors.